
Robert Alan Vigersky MD
Diabetes, Lipid Metabolism
Professor, Medicine, Uniformed Services Hebert SOM; Chief Medical Officer Medtronic/Minimed Diabetes
Join to view full profile
18000 Devonshire StreetNorthridge, CA 91325
Phone+1 202-394-5395
Fax+1 202-294-7640
Dr. Vigersky is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Johns Hopkins UniversityResidency, Internal Medicine, 1970 - 1972
Boston University School of MedicineClass of 1970
Certifications & Licensure
DC State Medical License 1978 - 2027
MD State Medical License 1976 - 2027
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Endocrinology, Diabetes and Metabolism
Clinical Trials
Publications & Presentations
PubMed
- Sustained Glycemic Outcomes with the MiniMed780G System: Real-World Evidence from >16,000 Users Across 18 Latin American Countries Over Two Years.Matias Castro, Bruno Grassi, Alejandro Daín, Ana María Gómez, Antonio Saleme
Diabetes Technology & Therapeutics. 2026-09-19 - Authors' Response to LTE by Scaramuzza et al.Maya Laron-Hirsh, Sapir Barel, Anirban Roy, George Mallas, Benyamin Grossman
Diabetes Technology & Therapeutics. 2026-08-20 - 4 citationsPerformance of an Automated Insulin Delivery System in People Living With Type 2 Diabetes and Insulin Resistance: First Real-World Evidence in 26,427 Users.Isabeau Thijs, Arcelia Arrieta, Javier Castañeda, Michael Joubert, Francesco Giorgino
Journal of Diabetes Science and Technology. 2026-07-01
Press Mentions
Data Backs Medtronic MiniMed 780G for Type 2, Children as Company Seeks Expanded IndicationsJune 20th, 2025
FDA Rules Medtronic’s Insulin Pump Issues a Class I Recall Due to Safety RisksOctober 4th, 2024
Increasing Access to Diabetes Technology for Children with Type 1 DiabetesMay 12th, 2023
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: